h1

h2

h3

h4

h5
h6

001     945838
005     20250925171105.0
024 7 _ |2 HSB
|a eva522491
024 7 _ |2 ISSN
|a 0278-0232
024 7 _ |2 ISSN
|a 1099-1069
024 7 _ |2 SCOPUS
|a SCOPUS:2-s2.0-85143207713
024 7 _ |2 WOS
|a WOS:000892456700001
024 7 _ |2 datacite_doi
|a 10.18154/RWTH-CONV-250797
024 7 _ |2 doi
|a 10.1002/hon.3100
024 7 _ |2 pmid
|a pmid:36383121
037 _ _ |a RWTH-CONV-250797
041 _ _ |a English
100 1 _ |0 P:(DE-82)019627
|a Wilhelm, Thomas
|b 0
|e Corresponding author
|u rwth
245 _ _ |a Capitalizing on paradoxical activation of the mitogen-activated protein kinase pathway for treatment of Imatinib-resistant mast cell leukemia
|h online, print
260 _ _ |a New York, NY [u.a.]
|b Wiley Interscience
|c 2023
260 _ _ |c 2022
336 7 _ |0 0
|2 EndNote
|a Journal Article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
500 _ _ |a First published: 16 November 2022
536 _ _ |0 G:(DE-82)X021000-OA
|a OA - Open Access Publikation mit Unterstützung der Universitätsbibliothek der RWTH Aachen University (X021000-OA)
|c X021000-OA
|x 0
591 _ _ |a France
591 _ _ |a Germany
700 1 _ |0 P:(DE-588)1238644163
|a de Toledo, Marcelo A. S.
|b 1
|u rwth
700 1 _ |0 P:(DE-82)951594
|a Simons, Ilka
|b 2
|u rwth
700 1 _ |0 P:(DE-82)951595
|a Stuth, Christian
|b 3
|u rwth
700 1 _ |0 P:(DE-588)1208793519
|a Mohta, Vrinda
|b 4
|u rwth
700 1 _ |0 P:(DE-82)951597
|a Mülfarth, Ronja
|b 5
|u rwth
700 1 _ |0 P:(DE-82)951598
|a Nitsche, Marcus
|b 6
|u rwth
700 1 _ |0 P:(DE-82)172891
|a Maschke-Neuß, Karin
|b 7
|u rwth
700 1 _ |0 P:(DE-82)096127
|a Schmitz, Susanne
|b 8
|u rwth
700 1 _ |0 P:(DE-82)951599
|a Kaiser, Anne
|b 9
|u rwth
700 1 _ |0 P:(DE-82)IDM05999
|a Panse, Jens Peter
|b 10
|u rwth
700 1 _ |0 P:(DE-82)711181
|a Christen, Deborah
|b 11
|u rwth
700 1 _ |a Arock, Michel
|b 12
700 1 _ |0 P:(DE-82)IDM00384
|a Zenke, Martin
|b 13
|u rwth
700 1 _ |0 P:(DE-82)IDM06005
|a Huber, Michael
|b 14
|u rwth
773 _ _ |0 PERI:(DE-600)2001443-0
|a 10.1002/hon.3100
|n 3
|p 520-534
|t Hematological oncology
|v 41
|x 1099-1069
856 4 _ |u https://publications.rwth-aachen.de/record/945838/files/945838.pdf
|y OpenAccess
876 7 _ |c 2750.00
|d 2023-08-07
|e Hybrid-OA
|j DEAL
|x 021000
|z DEAL
909 C O |o oai:publications.rwth-aachen.de:945838
|p openaire
|p open_access
|p openCost
|p driver
|p dnbdelivery
|p VDB
|p OpenAPC_DEAL
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)019627
|a RWTH Aachen
|b 0
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-588)1238644163
|a RWTH Aachen
|b 1
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)951594
|a RWTH Aachen
|b 2
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)951595
|a RWTH Aachen
|b 3
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-588)1208793519
|a RWTH Aachen
|b 4
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)951597
|a RWTH Aachen
|b 5
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)951598
|a RWTH Aachen
|b 6
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)172891
|a RWTH Aachen
|b 7
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)096127
|a RWTH Aachen
|b 8
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)951599
|a RWTH Aachen
|b 9
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM05999
|a RWTH Aachen
|b 10
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)711181
|a RWTH Aachen
|b 11
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM00384
|a RWTH Aachen
|b 13
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-82)IDM06005
|a RWTH Aachen
|b 14
|k RWTH
914 1 _ |y 2022
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
|a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b HEMATOL ONCOL : 2021
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b HEMATOL ONCOL : 2022
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)0420
|2 StatID
|a Nationallizenz
|d 2022-11-26
|w ger
915 _ _ |0 StatID:(DE-HGF)0420
|2 StatID
|a Nationallizenz
|d 2023-08-22
|w ger
915 _ _ |0 StatID:(DE-HGF)0510
|2 StatID
|a OpenAccess
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)1190
|2 StatID
|a DBCoverage
|b Biological Abstracts
|d 2023-08-22
915 _ _ |0 StatID:(DE-HGF)3001
|2 StatID
|a DEAL Wiley
|d 2022-11-26
|w ger
915 _ _ |0 StatID:(DE-HGF)3001
|2 StatID
|a DEAL Wiley
|d 2023-08-22
|w ger
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2022-11-26
915 _ _ |0 StatID:(DE-HGF)9900
|2 StatID
|a IF < 5
|d 2023-08-22
915 p c |0 PC:(DE-HGF)0000
|2 APC
|a APC keys set
915 p c |0 PC:(DE-HGF)0120
|2 APC
|a DEAL: Wiley 2019
920 1 _ |0 I:(DE-82)513000-3_20140620
|k 513000-3
|l Institut und Lehr- und Forschungsgebiet Biochemie und Molekulare Immunologie
|x 0
920 1 _ |0 I:(DE-82)9795200_20140620
|k 9795200
|l Institut für Biomedizinische Technologien - Zellbiologie
|x 1
920 1 _ |0 I:(DE-82)029000_20200506
|k 029000
|l Helmholtz-Institut für Biomedizinische Technik
|x 2
920 1 _ |0 I:(DE-82)531040-2_20140620
|k 531040-2
|l Klinik für Onkologie, Hämatologie und Stammzelltransplantation (Med. Klinik IV)
|x 3
970 _ _ |a eva522491
980 1 _ |a FullTexts
980 _ _ |a APC
980 _ _ |a I:(DE-82)029000_20200506
980 _ _ |a I:(DE-82)513000-3_20140620
980 _ _ |a I:(DE-82)531040-2_20140620
980 _ _ |a I:(DE-82)9795200_20140620
980 _ _ |a UNRESTRICTED
980 _ _ |a VDB
980 _ _ |a journal

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21